Market Size of Arbovirus Testing Industry
Study Period | 2019 - 2029 |
Market Size (2024) | USD 0.86 Billion |
Market Size (2029) | USD 1.14 Billion |
CAGR (2024 - 2029) | 5.92 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Arbovirus Testing Market Analysis
The Arbovirus Testing Market size is estimated at USD 0.86 billion in 2024, and is expected to reach USD 1.14 billion by 2029, growing at a CAGR of 5.92% during the forecast period (2024-2029).
- The major factors accounting for the growth of the arbovirus testing market are the increasing rate of incidence and prevalence of Arbovirus throughout the world, recent advancements in technology, and emerging rapid Serology Tests that may drive the arbovirus testing market during the forecast period.
- For example, WHO has reported that the number of dengue cases reported increased over 15-fold over the last two decades, from 505,430 cases in 2000 to over 2,400,138 in 2010 and 3,312,040 in 2015. Deaths from 2000 to 2015 increased from 960 to more than 4032, which strongly supports the increase in the incidence of arboviral diseases.
- Thus, the incidence rate of Arboviral diseases drives the growth of the arbovirus testing market during the forecast period. However, the lack of in vitro facilities, lack of awareness, and limited availability of diagnostic testing procedures may restrain the studied market's growth during the forecast period.
Arbovirus Testing Industry Segmentation
Arboviruses (Arthropod-borne viruses) are a unique, diverse, and fascinating group of viruses because they cycle between a wide variety of vertebrate hosts and arthropod species. Examples of the arboviral infectious diseases include Dengue, Chikungunya, St. Louis encephalitis, Yellow fever, California encephalitis, Eastern Equine Encephalitis, Powassan, West Nile, and Zika.
By Test Type | |
ELISA-based Tests | |
RT-PCR based Tests | |
Other Test Types |
By End User | |
Diagnostic Laboratories | |
Hospitals | |
Research Centers | |
Other End Users |
By Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Arbovirus Testing Market Size Summary
The arbovirus testing market is poised for significant growth, driven by the increasing incidence and prevalence of arboviral diseases globally. Technological advancements and the emergence of rapid serology tests are key factors propelling market expansion. The rising number of dengue cases, as reported by the WHO, underscores the growing demand for effective testing solutions. Despite these growth drivers, challenges such as limited in vitro facilities, lack of awareness, and restricted availability of diagnostic procedures may hinder market progress. The RT-PCR based tests segment is anticipated to lead the market due to its superior detection limits and sensitivity compared to ELISA methods, along with reduced laboratory waste.
Regionally, North America is expected to maintain its dominance in the arbovirus testing market, supported by a developed economy, increased healthcare spending, and the adoption of advanced technological products. Meanwhile, the Asia-Pacific region is projected to experience a high growth rate, attributed to its dense population, which facilitates the spread of arboviral diseases. The market is moderately competitive, with major players like Agilent Technologies Inc., Thermo Fisher Scientific, and Abbott Laboratories driving innovation and competition. The ongoing consolidation and product recalls in the healthcare sector are likely to intensify competitive rivalry among key market participants.
Arbovirus Testing Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increase in the Incidence and Prevalence of Arbovirus
-
1.2.2 Advancement in Technology
-
1.2.3 Rapid Serology Tests
-
-
1.3 Market Restraints
-
1.3.1 Lack of In vitro Facilities
-
1.3.2 Lack of Awareness and Limited Availability of Diagnostic Testing Procedures
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Test Type
-
2.1.1 ELISA-based Tests
-
2.1.2 RT-PCR based Tests
-
2.1.3 Other Test Types
-
-
2.2 By End User
-
2.2.1 Diagnostic Laboratories
-
2.2.2 Hospitals
-
2.2.3 Research Centers
-
2.2.4 Other End Users
-
-
2.3 By Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle East & Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle East & Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Arbovirus Testing Market Size FAQs
How big is the Arbovirus Testing Market?
The Arbovirus Testing Market size is expected to reach USD 0.86 billion in 2024 and grow at a CAGR of 5.92% to reach USD 1.14 billion by 2029.
What is the current Arbovirus Testing Market size?
In 2024, the Arbovirus Testing Market size is expected to reach USD 0.86 billion.